Acute Care Kit

Manufacturer
MARPE LLC | OHM PHARMA INC.
Effective date
2014-04-30
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:05:41

Label at a glance#

ProductAcute Care Kit
Active ingredientACONITUM NAPELLUS, ANTIMONY POTASSIUM TARTRATE, APIS MELLIFERA, ARNICA MONTANA, ARSENIC TRIOXIDE, ATROPA BELLADONNA, LYTTA VESICATORIA, ACTIVATED CHARCOAL, MATRICARIA RECUTITA, CINCHONA OFFICINALIS BARK, GELSEMIUM SEMPERVIRENS ROOT, CALCIUM SULFIDE, HYPERICUM PERFORATUM, IPECAC, POTASSIUM DICHROMATE, LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORUS, PULSATILLA VULGARIS, TOXICODENDRON PUBESCENS LEAF, URTICA URENS
Label structure6 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS (HPUS*): ACONITUM NAPELLUS 30C, ANTIMONIUM TARTARICUM 30C, APIS MELLIFICA 30C, APIS MELLIFICA 200C, ARNICA MONTANA 30C, ARNICA MONTANA 200C, ARSENICUM ALBUM 30C, BELLADONNA 30C, CANTHARIS 30C, CARBO VEGETABILIS 30C, CARBO VEGETABILIS 200C, CHAMOMILLA 30C, CHINA OFFICINALIS 30C, GELSEMIUM SEMPERVIRENS 30C, HEPAR SULPHURIS CALCAREUM 30C, HYPERICUM PERFORATUM 30C, IPECACUANHA 30C, KALI BICHROMICUM 30C, LACHESIS MUTUS 30C, LYCOPODIUM CLAVATUM 30C, NUX VOMICA 30C, PHOSPHORUS 30C, PULSATILLA 30C, RHUS TOXICODENDRON 30C, URTICA URENS 30C.

OTHER SAFETY INFORMATION

* The letters “HPUS” indicate that the components in this product are officially monographed in the Homoeopathic Pharmacopoeia of  the United States.

INDICATIONS & USAGE SECTION

USES: See the included remedy guide for more information.

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS: Adults/Children: Dissolve 3-5 pellets in mouth 3 times a day for up to 7 days or as directed by a health care practitioner.

WARNINGS SECTION

WARNING:
Do not use if seal is broken. If you are pregnant or nursing, consult your health care practitioner before use. Store in a cool, dry place. If symptoms persist or worsen, discontinue use and contact a licensed health care practitioner.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF THE REACH OF CHILDREN.

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENT: Sucrose. Lactose - free.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

  • NDC: 62990-690-18


Nature Kits by Marpe

ACUTE CARE KIT

Dr. Brown's Top Remedies for First Aid and Self Limiting Conditions


  • 25 HOMEOPATHIC MEDICINES


front label
front label

inside label
inside label

back label
back label

OTC - PURPOSE SECTION

Dr. Brown's Top Remedies for First Aid and Self Limiting Conditions

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
63f39a63-5cd1-4016-bd86-2bbb0f6c3139Product name320240506
e5a77e9c-c528-733a-173d-914a234c024bProduct name520240506

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
62990-690-182019-11-27C16284748780-19855e2a2-3618-60a7-e053-dbdaa90a05bdACUTE CARE KIT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62990-690-18Acute Care Kit25 in 1 KITPELLET252

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62990-690ACUTE CARE KIT (ACONITUM NAPELLUS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, CANTHARIS, CARBO VEGETABILIS, CHAMOMILLA, CINCHONA, GELSEMIUM, HEPAR SULPH CALCAREUM, HYPERICUM PERFORATURM, IPECACUANHA, KALI BICHROMICUM, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORUS, PULSATILLA, RHUS TOXICODENDRON, URTICA URENS) PELLET [MARPE LLC]2Legacy NDC, 1 package rows20140501_fd964c61-4ab4-4865-8607-811c4d394030.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ACONITUM NAPELLUSACTIVE INGREDIENTU0NQ8555JD2
ACTIVATED CHARCOALACTIVE INGREDIENT2P3VWU3H102
ANTIMONY POTASSIUM TARTRATEACTIVE INGREDIENTDL6OZ476V32
APIS MELLIFERAACTIVE INGREDIENT7S82P3R43Z2
ARNICA MONTANAACTIVE INGREDIENTO80TY208ZW2
ARSENIC TRIOXIDEACTIVE INGREDIENTS7V92P67HO2
ATROPA BELLADONNAACTIVE INGREDIENTWQZ3G9PF0H2
CALCIUM SULFIDEACTIVE INGREDIENT1MBW07J51Q2
CINCHONA OFFICINALIS BARKACTIVE INGREDIENTS003A158SB2
GELSEMIUM SEMPERVIRENS ROOTACTIVE INGREDIENT639KR60Q1Q2
HYPERICUM PERFORATUMACTIVE INGREDIENTXK4IUX8MNB2
IPECACACTIVE INGREDIENT62I3C8233L2
LACHESIS MUTA VENOMACTIVE INGREDIENTVSW71SS07I2
LYCOPODIUM CLAVATUM SPOREACTIVE INGREDIENTC88X29Y4792
LYTTA VESICATORIAACTIVE INGREDIENT3Q034RO3BT2
MATRICARIA RECUTITAACTIVE INGREDIENTG0R4UBI2ZZ2
PHOSPHORUSACTIVE INGREDIENT27YLU75U4W2
POTASSIUM DICHROMATEACTIVE INGREDIENTT4423S18FM2
PULSATILLA VULGARISACTIVE INGREDIENTI76KB35JEV2
STRYCHNOS NUX-VOMICA SEEDACTIVE INGREDIENT269XH139192
TOXICODENDRON PUBESCENS LEAFACTIVE INGREDIENT6IO182RP7A2
URTICA URENSACTIVE INGREDIENTIHN2NQ5OF92
ACONITUM NAPELLUSACTIVE MOIETYU0NQ8555JD2
ACTIVATED CHARCOALACTIVE MOIETY2P3VWU3H102
ANTIMONY CATION (3+)ACTIVE MOIETY069647RPT52
APIS MELLIFERAACTIVE MOIETY7S82P3R43Z2
ARNICA MONTANAACTIVE MOIETYO80TY208ZW2
ARSENIC CATION (3+)ACTIVE MOIETYC96613F5AV2
ATROPA BELLADONNAACTIVE MOIETYWQZ3G9PF0H2
CALCIUM SULFIDEACTIVE MOIETY1MBW07J51Q2
CINCHONA OFFICINALIS BARKACTIVE MOIETYS003A158SB2
DICHROMATE IONACTIVE MOIETY9LKY4BFN2V2
GELSEMIUM SEMPERVIRENS ROOTACTIVE MOIETY639KR60Q1Q2
HYPERICUM PERFORATUMACTIVE MOIETYXK4IUX8MNB2
IPECACACTIVE MOIETY62I3C8233L2
LACHESIS MUTA VENOMACTIVE MOIETYVSW71SS07I2
LYCOPODIUM CLAVATUM SPOREACTIVE MOIETYC88X29Y4792
LYTTA VESICATORIAACTIVE MOIETY3Q034RO3BT2
MATRICARIA RECUTITAACTIVE MOIETYG0R4UBI2ZZ2
PHOSPHORUSACTIVE MOIETY27YLU75U4W2
PULSATILLA VULGARISACTIVE MOIETYI76KB35JEV2
STRYCHNOS NUX-VOMICA SEEDACTIVE MOIETY269XH139192
TOXICODENDRON PUBESCENS LEAFACTIVE MOIETY6IO182RP7A2
URTICA URENSACTIVE MOIETYIHN2NQ5OF92
SUCROSEINACTIVE INGREDIENTC151H8M5542

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62990-69062990-690-18

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SUCROSESUCROSEC151H8M554POWDER, FOR SOLUTION / ORAL38666 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554CAPSULE, COATED PELLETS / ORAL59.8 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554GRANULE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554POWDER, FOR SUSPENSION / ORAL40017 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SUSPENSION / ORAL48209 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554LOZENGE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554GRANULE, FOR SUSPENSION / ORAL31885 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554CAPSULE / ORAL3568 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554LIQUID / ORAL37500 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET / ORAL4249 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL18790 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SUPPOSITORY / RECTALNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554CONCENTRATE / ORAL4800 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS2000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554CAPSULE, EXTENDED RELEASE / ORAL619 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS9.4 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS900 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET, EXTENDED RELEASE / ORAL284.54 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, SOLUTION / INTRAVENOUSNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET, FILM COATED, EXTENDED RELEASE / ORAL119.12 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET, COATED / ORAL516.42 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET / SUBLINGUAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554CAPSULE, COATED, EXTENDED RELEASE / ORAL86 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554GRANULE, FOR SOLUTION / ORAL42596 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS308 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET, CHEWABLE / ORAL7258 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTABLE, LIPOSOMAL / INTRAVENOUS7560 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SYRUP / ORAL46400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554CAPSULE, DELAYED RELEASE / ORAL955 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SUSPENSION/ DROPS / ORAL3750 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554ELIXIR / ORAL18000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554WAFER / ORAL155.2 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554PASTILLE / ORAL426 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET, FILM COATED / ORAL145 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION / INTRAVENOUS1950 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION / SUBCUTANEOUS47.75 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SUSPENSION, EXTENDED RELEASE / ORAL5400 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554DROPS / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS1 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554INJECTION, EMULSION / INTRAVENOUS970 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554POWDER / ORAL27768 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554LOZENGE / TRANSMUCOSAL1255 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TROCHE / BUCCALNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET / BUCCAL109 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SOLUTION / ORAL70000 mgExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554SOLUTION / RECTAL35.42 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TROCHE / ORALNAExact identifier — unii candidate
48 equally ranked IID candidates
SUCROSESUCROSEC151H8M554TABLET, DELAYED RELEASE / ORAL295.33 mgExact identifier — unii candidate
48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b76a0c0a-cd16-4ff6-b17e-9a42b11ab6f6fd964c61-4ab4-4865-8607-811c4d3940302014-04-30WarningsExact identifier
spl id: b76a0c0a-cd16-4ff6-b17e-9a42b11ab6f6
spl set id: fd964c61-4ab4-4865-8607-811c4d394030

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.